Date(s) - 14 Sep 2020
10:00 AM - 11:00 AM
The Critical Path Institute: 15 Years of Impact
Presented Virtually Via Webex.
Register for this and other free Arizona Bioscience Week Educational Events via the AZBW2020 App
A catalyst in the development of new tools and approaches to advance regulatory science and medical product development, Tucson-based Critical Path Institute has been leading teams that share data, knowledge and expertise resulting in sound, consensus-based science for more than 15 years. Even through these unprecedented times, C-Path continues to forge ahead, charting new territory and laying the groundwork for innovative drug development that will lead to treatments and cures for patients around the globe.
Klaus Romero MD, MS, FCP is a clinical pharmacologist and epidemiologist by training, with 15 years combined experience in academic clinical research. Dr. Romero has been with C-Path since December of 2007, and during his tenure, he has helped lead clinical pharmacology, pharmacoepidemiology and modeling and simulation projects in Alzheimer’s disease, polycystic kidney disease, tuberculosis, type 1 diabetes, Parkinson’s disease, Duchenne muscular dystrophy, kidney transplantation and Huntington’s disease, achieving major milestones such as the first regulatory endorsement by FDA and EMA of a clinical trial simulation tool for mild and moderate Alzheimer’s Disease and the qualification of an imaging prognostic biomarker for PKD. He is a fellow of the American College of Clinical Pharmacology and the American Society for Clinical Pharmacology and Therapeutics.